The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(42 sites)

China

Bozhou People's Hospital, Bozhou, Anhui

Chuzhou First People's Hospital, Chuzhou, Anhui

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui

Aviation General Hospital, Beijing, Beijing Municipality

China-Japan Friendship Hospital, Beijing, Beijing Municipality